Department of Zoology, University of Delhi, New Delhi, Delhi, 110007, India.
Inflamm Res. 2022 Dec;71(12):1477-1488. doi: 10.1007/s00011-022-01627-6. Epub 2022 Oct 26.
Neutrophils are the key cells of our innate immune system with a primary role in host defense. They rapidly arrive at the site of infection and display a range of effector functions including phagocytosis, degranulation, and NETosis to eliminate the invading pathogens. However, in recent years, studies focusing on neutrophil biology have revealed the highly adaptable nature and versatile functions of these cells which extend beyond host defense. Neutrophils are now referred to as powerful mediators of chronic inflammation. In several chronic inflammatory diseases, their untoward actions, such as immense infiltration, hyper-activation, dysregulation of effector functions, and extended survival, eventually contribute to disease pathogenesis. Therefore, a better understanding of neutrophils and their effector functions in prevalent chronic diseases will not only shed light on their role in disease pathogenesis but will also reveal them as novel therapeutic targets.
We performed a computer-based online search using the databases, PubMed.gov and Clinical trials.gov for published research and review articles.
This review provides an assessment of neutrophils and their crucial involvement in various chronic inflammatory disorders ranging from respiratory, neurodegenerative, autoimmune, and cardiovascular diseases. In addition, we also discuss the therapeutic approach for targeting neutrophils in disease settings that will pave the way forward for future research.
中性粒细胞是我们先天免疫系统的关键细胞,在宿主防御中起主要作用。它们迅速到达感染部位,并表现出一系列效应功能,包括吞噬、脱颗粒和 NETosis,以消除入侵的病原体。然而,近年来,对中性粒细胞生物学的研究揭示了这些细胞高度适应性和多功能的本质,其功能超出了宿主防御。中性粒细胞现在被称为慢性炎症的有力介质。在几种慢性炎症性疾病中,它们的不良作用,如大量浸润、过度激活、效应功能失调和延长存活,最终导致疾病发病机制。因此,更好地了解中性粒细胞及其在常见慢性疾病中的效应功能,不仅将阐明它们在疾病发病机制中的作用,还将揭示它们作为新型治疗靶点的潜力。
我们使用数据库 PubMed.gov 和 Clinicaltrials.gov 进行了基于计算机的在线搜索,以查找已发表的研究和综述文章。
本综述评估了中性粒细胞及其在各种慢性炎症性疾病中的关键作用,包括呼吸道、神经退行性、自身免疫和心血管疾病。此外,我们还讨论了针对疾病状态下中性粒细胞的治疗方法,为未来的研究铺平了道路。